deltatrials
Active Not Recruiting PHASE2 INTERVENTIONAL 4-arm NCT01783535

Protocol for the Study and Treatment of Participants With Intraocular Retinoblastoma

Sponsor: St. Jude Children's Research Hospital

Conditions Retinoblastoma
Interventions MESNA PEG-filgrastim carboplatin cyclophosphamide doxorubicin enucleation etoposide external beam radiation or proton beam radiation filgrastim focal therapy topotecan vincristine
Updated 19 times since 2017 Last updated: Apr 11, 2024 Started: Jun 19, 2013 Primary completion: Mar 17, 2023 Completion: Jan 31, 2028
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01783535, this PHASE2 trial focuses on Retinoblastoma and remains ongoing. Sponsored by St. Jude Children's Research Hospital, it has been updated 19 times since 2013, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~May 2017 · 3 months · monthly snapshot~May 2017 – ~Jun 2018 · 13 months · monthly snapshot~Jun 2018 – ~Nov 2018 · 5 months · monthly snapshot~Nov 2018 – ~Nov 2019 · 12 months · monthly snapshot~Nov 2019 – ~Aug 2020 · 9 months · monthly snapshot~Aug 2020 – ~Oct 2020 · 2 months · monthly snapshot~Oct 2020 – ~Dec 2020 · 2 months · monthly snapshot~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Jan 2022 · 11 months · monthly snapshot~Jan 2022 – ~Feb 2022 · 31 days · monthly snapshot~Feb 2022 – ~Jul 2022 · 5 months · monthly snapshot~Jul 2022 – ~Sep 2022 · 2 months · monthly snapshot~Sep 2022 – ~Apr 2023 · 7 months · monthly snapshot~Apr 2023 – ~May 2024 · 13 months · monthly snapshot~May 2024 – ~Jul 2024 · 2 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 24 months · monthly snapshot

Change History

19 versions recorded

  1. Sep 2024 — Present [monthly]

    Active Not Recruiting PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting PHASE2

  3. May 2024 — Jul 2024 [monthly]

    Active Not Recruiting PHASE2

  4. Apr 2023 — May 2024 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  5. Sep 2022 — Apr 2023 [monthly]

    Recruiting PHASE2

▶ Show 14 earlier versions

  1. Jul 2022 — Sep 2022 [monthly]

    Recruiting PHASE2

  2. Feb 2022 — Jul 2022 [monthly]

    Recruiting PHASE2

  3. Jan 2022 — Feb 2022 [monthly]

    Recruiting PHASE2

  4. Feb 2021 — Jan 2022 [monthly]

    Recruiting PHASE2

  5. Jan 2021 — Feb 2021 [monthly]

    Recruiting PHASE2

  6. Dec 2020 — Jan 2021 [monthly]

    Recruiting PHASE2

  7. Oct 2020 — Dec 2020 [monthly]

    Recruiting PHASE2

  8. Aug 2020 — Oct 2020 [monthly]

    Recruiting PHASE2

  9. Nov 2019 — Aug 2020 [monthly]

    Recruiting PHASE2

  10. Nov 2018 — Nov 2019 [monthly]

    Recruiting PHASE2

  11. Jun 2018 — Nov 2018 [monthly]

    Recruiting PHASE2

  12. May 2017 — Jun 2018 [monthly]

    Recruiting PHASE2

  13. Feb 2017 — May 2017 [monthly]

    Recruiting PHASE2

  14. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE2

    First recorded

Jun 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • St. Jude Children's Research Hospital
Data source: St. Jude Children's Research Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations